MoneyWorks4Me

The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 31.33 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2024 of Rs. 0.90 millions grew from Rs.-3.04 millions Operating profit Margin for the quarter ended March 2024 improved to 3.60% as compared to -2.13% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 31.33 0.00 0.00 102.88 10.04 924.70 102.88 10.04 924.70
Other Income 0.98 0.00 0.00 3.33 3.99 -16.54 3.33 3.99 -16.54
PBIDT 3.60 -2.13 -269.01 -32.39 -40.45 -19.93 -32.39 -40.45 -19.93
Interest 2.78 2.57 8.17 12.20 12.14 0.49 12.20 12.14 0.49
PBDT 0.82 -4.70 -117.45 -44.59 -52.59 -15.21 -44.59 -52.59 -15.21
Depreciation 1.81 1.54 17.53 7.20 6.18 16.50 7.20 6.18 16.50
PBT -0.99 -6.24 -84.13 -51.79 -58.77 -11.88 -51.79 -58.77 -11.88
TAX -1.89 -3.20 -40.94 -6.65 -2.15 209.30 -6.65 -2.15 209.30
Deferred Tax -1.89 -3.20 -40.94 -6.65 8.38 -179.36 -6.65 8.38 -179.36
PAT 0.90 -3.04 -129.61 -45.14 -56.62 -20.28 -45.14 -56.62 -20.28
Equity 94.33 75.11 25.59 94.33 75.11 25.59 94.33 75.11 25.59
PBIDTM(%) 11.49 0.00 0.00 -31.48 -402.89 -92.19 -31.48 -402.89 -92.19
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..